Skip to main content
. 2020 Feb 4;19(4):1099–1107. doi: 10.5114/aoms.2020.92869

Figure 1.

Figure 1

A – Expression of miR-325 in normal and breast cancer tissues. B – Expression of miR-325 in normal MB 157 and different breast cancer cell lines. C – Expression of miR-325 in miR-NC and miR-325 mimic transfected SK-BR-3 and CAMA-1 cells. D – Cell viability of miR-NC and miR-325 mimic transfected SK-BR-3 and CAMA-1 cells. The experiments were performed in triplicate and expressed as mean ± SD (*p < 0.05)